Search details
1.
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.
Intensive Care Med
; 47(8): 867-886, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34251506
Results
1 -
1
de 1
1
Next >
>>